Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich
Nina
N
Department of Rheumatology, Bnai Zion Medical Center, and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. rosneri@tx.technion.ac.il
Boulman
Nina
N
Slobodin
Gleb
G
Zeina
Abdel-Rauf
AR
Rosner
Itzhak
I
Rozenbaum
Michael
M
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018450:Disease Progression; D014890:Granulomatosis with Polyangiitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009916:Orbital Diseases / Q000188:drug therapy; D012074:Remission Induction; D000069283:Rituximab; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D019268:Antibodies, Antineutrophil Cytoplasmic; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab